Explore more publications!
Health Times of Rhode Island
Got News to Share?

Health Times of Rhode Island: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times of Rhode Island.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 16, 2026

Kailera Therapeutics Announces Pricing of Initial Public Offering
Apr. 16, 2026

Kailera Therapeutics Announces Pricing of Initial Public Offering

Indeterminate GlobeNewswire
Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto
Apr. 16, 2026

Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in Toronto

Indeterminate GlobeNewswire
Extendicare Announces Voting Results for its 2026 Annual Meeting of Shareholders
Apr. 16, 2026

Extendicare Announces Voting Results for its 2026 Annual Meeting of Shareholders

Indeterminate GlobeNewswire
JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
Apr. 16, 2026

JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering

Indeterminate GlobeNewswire
OsteoShield Claims Evaluated: Premium-Quality Bone Density Support Formula by Peak Health Research
Apr. 16, 2026

OsteoShield Claims Evaluated: Premium-Quality Bone Density Support Formula by Peak Health Research

Indeterminate GlobeNewswire
Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year
Apr. 16, 2026

Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year

Indeterminate GlobeNewswire
Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems
Apr. 16, 2026

Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems

Indeterminate GlobeNewswire
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Apr. 16, 2026

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Indeterminate GlobeNewswire
VapoFil Under Investigation: Evaluating the Vapor Rub Male Enhancement Honey Trick Claims
Apr. 16, 2026

VapoFil Under Investigation: Evaluating the Vapor Rub Male Enhancement Honey Trick Claims

Indeterminate GlobeNewswire
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million
Apr. 16, 2026

Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million

Indeterminate GlobeNewswire
LifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 2026
Apr. 16, 2026

LifeStance to Host First Quarter 2026 Earnings Conference Call on May 7, 2026

Indeterminate GlobeNewswire
Trevi Therapeutics Announces Proposed Public Offering of Common Stock
Apr. 16, 2026

Trevi Therapeutics Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
PacBio to Report First Quarter 2026 Financial Results on May 7, 2026
Apr. 16, 2026

PacBio to Report First Quarter 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire
OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026
Apr. 16, 2026

OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026

Indeterminate GlobeNewswire
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
Apr. 16, 2026

Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility

Indeterminate GlobeNewswire
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
Apr. 16, 2026

Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026

Indeterminate GlobeNewswire
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Apr. 16, 2026

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock
Apr. 16, 2026

Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock

Indeterminate GlobeNewswire
TerrAscend Appoints Eric Jackson as Chief Financial Officer
Apr. 16, 2026

TerrAscend Appoints Eric Jackson as Chief Financial Officer

Indeterminate GlobeNewswire
New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026
Apr. 16, 2026

New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions